This is an aggregated industry headline. Read the full story at Drug Channels →
The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground (rerun)
This week, we're rerunning some popular posts while we prepare for tomorrow's live video webinar: 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders. Click here to see the original post from April 2026. By Adam J. Fein, Ph.D.Drug Channels Institute's (DCI's) latest anal
By Drug Channels
· Jun 11, 2026
· via Drug Channels
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Contract manufacturing powerhouse Lonza is growing in more ways than one. The Swiss company revealed this week…
The WeekFierceBiotech ↗
United Therapeutics has paid $140 million to buy Thymmune Therapeutics for preclinical regenerative cell thera…
The WeekBriefing
China’s approval of a CAR‑T for solid tumors breaks a scientific barrier and raises pressure on U.S. developer…